Drugs / Group ACYW135 Meningococcal Polysaccharide Vaccine
Group ACYW135 Meningococcal Polysaccharide Vaccine
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01661725 | Apr 2006 | meningitis | Hualan Biological Engineering, Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01661738 | May 2006 | meningitis | Hualan Biological Engineering, Inc. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT06314685 | Dec 2021 → Aug 2024 | — | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Group ACYW135 Meningococcal Polysaccharide Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06314685 ↗ |
| Modality | Vaccine | “Group ACYW135 Meningococcal Polysaccharide Vaccine” NCT01661725 ↗ |